Skip to main content

Advertisement

SpringerLink
Log in

Evaluation and management of periampullary tumors

  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

Periampullary cancers make up 5% of all gastrointestinal cancers. The complexity of the periampullary anatomy makes determination of the origin of some of these tumors difficult. However, advances in imaging have helped with diagnosis as well as defining the extent of the lesion and its potential resectability. For many of these tumors, surgery is the recommended treatment. However, endoscopic removal is being extended to different lesions with encouraging preliminary results. Improvements in overall prognosis for periampullary tumors will be limited until diagnosis can be established earlier in the course of the disease and adjuvant therapies become more effective.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Albores-Saavedra J, Henson DE, Klimstra DS: Tumors of the Gallbladder, Extrahepatic Bile Ducts and Ampulla of Vater. Washington DC: Armed Forces Institute of Pathology; 2000.

    Google Scholar 

  2. Sarmiento JM, Nagorney DM, Sarr MG, Farnell MB: Periampullary cancers: Are there differences? Surg Clin North Am 2001, 81:543–555.

    Article  PubMed  CAS  Google Scholar 

  3. Howe JR, Klimstra DS, Moccia RD, et al.: Factors predictive of survival in ampullary carcinoma. Ann Surg 1998, 87–94.

  4. Tsiotos GG, Farnell MB, Sarr MG: Are the results of pancreatectomy for pancreatic cancer improving? World J Surg 1999, 23:913–919.

    Article  PubMed  CAS  Google Scholar 

  5. Kim M-H, Lee S-K, Seo D-W, et al.: Tumors of the major duodenal papilla. Gastrointest Endosc 2001, 54:609–620. General review of papillary tumors.

    Article  PubMed  CAS  Google Scholar 

  6. Heidecke C-D, Rosenberg R, Bauer M, et al.: Impact of grade of dysplasia in villous adenoma of Vater’s papilla. World J Surg 2002, 26:709–714.

    Article  PubMed  Google Scholar 

  7. Cohen S, Bacon BR, Berlin JA, et al.: National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002. Gastrointest Endosc 2002, 56:803–809. New guidelines for the role of ERCP in pancreatobiliary disease.

    Article  PubMed  Google Scholar 

  8. Irie H, Honda H, Shinozaki K, et al.: MR imaging of ampullary carcinoma. J Comput Assist Tomogr 2002, 26:711–717.

    Article  PubMed  Google Scholar 

  9. Khan SA, Davidson BR, Goldin R, et al.:: Guidelines for the diagnosis and treatment of cholangiocarcinoma: a consensus document. Gut 2002, 51(Suppl 6):vi1-vi9. Reviews the current state of knowledge and approach to cholangiocarcinoma.

    Article  PubMed  Google Scholar 

  10. Salinger PF, Reilly M, Reynolds K, et al.: Is CT angiography sufficient for prediction of periampullary neoplasms? J Gastrointest Surg 2000, 4:233–239.

    Article  Google Scholar 

  11. Schwartz M, Pauls S, Sokiranski R, et al.: Is a preoperative multidiagnostic approach to predict surgical respectability of periampullary tumors still effective? Am J Surg 2001, 182:243–249.

    Article  Google Scholar 

  12. House MG, Yeo CJ, Cameron JL, et al.: Predicting respectability of periampullary cancer with three-dimensional computed tomography. J Gastrointest Surg 2004, 8:280–288.

    Article  PubMed  Google Scholar 

  13. Shoup M, Hodul P, Arawha GV, et al.: Defining a role for endoscopic ultrasound in staging periampullary tumors. Am J Surg 2000, 179:433–436.

    Article  Google Scholar 

  14. Chen C-H, Tseng L-J, Yang C-C, Yeh F-H: Preoperative evaluation of periampullary tumors by endoscopic sonography, transabdominal sonography, and computed tomography. J Clin Ultrasound 2001, 29:313–321.

    Article  PubMed  CAS  Google Scholar 

  15. Fritscher-Ravens A, Broering DC, Knoefel WT, et al.: EUS-Guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative cytology. Am J Gastroenterol 2003, 98:45–51.

    Google Scholar 

  16. Domagk D, Poremba C, Dietal K-H, et al.: Endoscopic transpapillary biopsies and intraductal ultrasonography in the diagnostics of bile duct strictures: a prospective study. Gut 2002, 51:240–244.

    Article  PubMed  CAS  Google Scholar 

  17. Vazquez-Sequeiros E, Baron TH, Clain JE, et al.: Evaluation of indeterminate bile duct strictures by intraductal ultrasound. Gastrointest Endosc 2002, 56:372–379.

    Article  PubMed  Google Scholar 

  18. Tamada K, Tomiyama T, Wada S, et al.: Endoscopic transpapillary bile duct biopsy with the combination of intraductal ultrasonography in the diagnosis of biliary strictures. Gut 2002, 50:326–531.

    Article  PubMed  CAS  Google Scholar 

  19. Itoh A, Goto H, Naitoh Y, et al.: Intraductal ultrasonograpy in diagnosing tumor extension of cancer of the papilla of Vater. Gastrointest Endosc 1997, 45:251–260.

    Article  PubMed  CAS  Google Scholar 

  20. Menzel J, Poremba C, Dietl K-H, et al.: Tumors of the papilla of Vater: inadequate diagnostic impact of endoscopic forceps biopsies taken prior to and following sphincterotomy. Ann Oncol 1999, 10:1227–1231.

    Article  PubMed  CAS  Google Scholar 

  21. Chak A, Isenberg G, Kobayashi K, et al.: Prospective evaluation of an over-the-wire catheter US probe. Gastrointest Endosc 2000, 51:202–205.

    Article  PubMed  CAS  Google Scholar 

  22. Kluge R, Schmidt F, Caca K, et al.: Positron emission tomography with [18F] fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology 2001, 33:1029–1035.

    Article  PubMed  CAS  Google Scholar 

  23. Kalady MR, Clary BM, Clark LA, et al.: Clinical utility of positron emissions tomography in the diagnosis and management of perimapullary neoplasms. Ann Surg Oncol 2002, 9:799–806.

    Article  PubMed  Google Scholar 

  24. Vogt M, Jacobs R, Riemann JF: Rationale for endoscopic management of adenoma of the papilla of Vater: options and limitations. Langenbecks Arch Surg 2001, 386:176–182.

    Article  PubMed  CAS  Google Scholar 

  25. Cannon ME, Carpenter SL, Elta GH, et al.: EUS compared with CT, magnetic resonance imaging and angiography and the influence of biliary stenting in staging accuracy of ampullary neoplasms. Gastrointest Endosc 1999, 50:27–33.

    Article  PubMed  CAS  Google Scholar 

  26. Esposito J, Friess H, Buchler MW: Carcinogenesis of cancer of the papilla and ampulla: pathophysiological facts and molecular biological mechanisms. Langenbecks Arch Surg 2001, 386:163–171.

    Article  PubMed  CAS  Google Scholar 

  27. Siqueira E, Schoen RE, Silverman W, et al.: Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. Gastro Endo 2002, 56:40–47.

    Article  Google Scholar 

  28. Lindberg B, Arnelo U, Bergquist A, et al.: Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreatography with special reference to patients with primary sclerosing cholangitis. Endoscopy 2002, 34:909–916.

    Article  PubMed  CAS  Google Scholar 

  29. Martin JA, Haber GB: Ampullary adenoma: clinical manifestations, diagnosis and treatment. Gastrointest Endosc Clinic N Am 2003, 13:649–69. Reviews the evolving approach to ampullary lesions.

    Article  Google Scholar 

  30. Desilets DJ, Dy RM, Ku PM, et al.: Endoscopic management of tumors of the major duodenal papilla: refined techniques to improve outcome and avoid complications. Gastrointest Endosc 2001, 54:202–208.

    PubMed  CAS  Google Scholar 

  31. Norton JD, Gostout CJ, Baron TH, et al.: Safety and outcome of endoscopic snare excision of the major duodenal papilla. Gastrointest Endosc 2002, 56:239–243.

    Article  PubMed  Google Scholar 

  32. Catalano MF, Linder JD, Chak A, et al.: Endoscopic management of adenoma of the major duodenal papilla. Gastrointest Endosc 2004, 59:225–232. Largest series with longest follow-up of adenomas removed endoscopically.

    Article  PubMed  Google Scholar 

  33. Zadorova S, Dvorak M, Hajer J: Endoscopic therapy of benign tumors of the papilla of Vater. Endoscopy 2001, 33:345–347.

    Article  PubMed  CAS  Google Scholar 

  34. Posner S, Colletti L, Knol J, et al.: Safety and long term efficacy of transduodenal excision for tumors of the ampulla of Vater. Surgery 2000, 128:694–701.

    Article  PubMed  CAS  Google Scholar 

  35. Beger HG, Treitschke F, Gansauge F, et al.: Tumor of the ampulla of Vater: experience with local and radical resection in 171 consecutively treated patients. Arch Surg 1999, 134:526–532.

    Article  PubMed  CAS  Google Scholar 

  36. Clary BM, Tyler DS, Dematos P, et al.: Local ampullary resection with careful intraoperative frozen section evaluation for presumed benign ampullary neoplasms. Surgery 2000, 127:628–633.

    Article  PubMed  CAS  Google Scholar 

  37. Jordan PH, Ayala G, Rosenberg WR, Kinner BM: Treatment of ampullary villous adenomas that may harbor carcinoma. J Gastrointest Surg 2002, 6:770–775.

    Article  PubMed  Google Scholar 

  38. Das A, Neugut AI, Cooper GS, Chak A: Association of ampullary and colorectal malignancies. Cancer 2004, 100:524–530.

    Article  PubMed  Google Scholar 

  39. Farnell MB, Sakorafas GH, Sarr MG, et al.: Villous tumors of the duodenum: reappraisal of local versus extended resection. J Gastrointest Surg 2000, 4:13–23.

    Article  PubMed  CAS  Google Scholar 

  40. Todoroki T, Koike N, Morishita Y, et al.: Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater. Ann Surg Oncol 2003, 10:1176–1183.

    Article  PubMed  Google Scholar 

  41. Duffy JP, Hines OJ, Liu JH, et al.: Improved survival for adenocarcinoma of the ampulla of Vater. Arch Surg 2003, 138:941–950.

    Article  PubMed  Google Scholar 

  42. Perez A, Saltzman JR, Carr-Locke DL, et al.: Benign nonampullary duodenal neoplasms. J Gastrointest Surg 2003, 7:536–541.

    Article  PubMed  Google Scholar 

  43. Murray MA, Zimmerman MJ, Ee HC: Sporadic duodenal adenoma is associated with colorectal neoplasia. Gut 2004, 53:261–265. Highlights the need for colonic evaluation in patients with duodenal adenomas.

    Article  PubMed  CAS  Google Scholar 

  44. Howe JR, Karnell LH, Menck HR, Scott-Conner C: Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985–95. Cancer 1999, 86:2693–2706.

    Article  PubMed  CAS  Google Scholar 

  45. Zyromski NJ, Kendrick ML, Nagorney DM, et al.: Duodenal carcinoid tumors: How aggressive should we be? J Gastrointest Surg 2001, 5:588–593.

    Article  PubMed  CAS  Google Scholar 

  46. Makhlouf HR, Burke AP, Sobin LH: Carcinoid tumors of the ampulla of Vater. Cancer 1999, 85:1241–1249.

    Article  PubMed  CAS  Google Scholar 

  47. Witzigmann H, Loracher C, Geissler F, et al.: Neuroendocrine tumors of the duodenum: clinical aspects, pathomorphology and therapy. Langenbeck Arch Surg 2002, 386:525–533.

    Article  Google Scholar 

  48. Riddell RH, Petras RE, Williams GT, Sobin LH: Atlas of Tumor Pathology: Tumors of the Intestines. Washington DC: Armed Forces Institute of Pathology; 2003.

    Google Scholar 

  49. Bakaeen FG, Murr MM, Sarr MG, et al.: What prognostic factors are important in duodenal adenocarcinoma? Arch Surg 2000, 135:635–642.

    Article  PubMed  CAS  Google Scholar 

  50. Ryder NM, Ko CY, Hines OJ, et al.: Primary duodenal adenocarcinoma. Arch Surg 2000, 135:1070–1075.

    Article  PubMed  CAS  Google Scholar 

  51. Sarela AJ, Brennan MF, Karpeh MS, et al.: Adenocarcinoma of the duodenum: importance of accurate lymph node staging and similarity of outcome to gastric cancer. Ann Surg Oncol 2004, 11:380–386. Large series from a major center stressing the importance of lymph node status in duodenal adenocarcinoma.

    Article  PubMed  Google Scholar 

  52. Oka S, Tanaka S, Nagata S, et al.: Clinicopathological features and endoscopic resection of early primary nonampullary duodenal carcinoma. J Clin Gastroenterol 2003, 37:381–386.

    Article  PubMed  Google Scholar 

  53. Kadmon M, Tandara A, Herfarth C: Duodenal adenomatosis in familial adenomatous polyposis coli: a review of the literature and results from the Heidelberg Polyposis Register. Int J Colorectal Dis 2001, 16:63–75.

    Article  PubMed  CAS  Google Scholar 

  54. Spigelman AD, Williams CB, Talbot IC, et al.: Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989, 2:783–785.

    Article  PubMed  CAS  Google Scholar 

  55. Burke CA, Beck GJ, Church JM, van Stolk RU: The natural history of untreated duodenal and ampullary adenomas in patients with familial adenomatous polyposis followed in an endoscopic surveillance program. Gastrointest Endosc 1999, 49:358–364.

    Article  PubMed  CAS  Google Scholar 

  56. Bulow S, Bjork J, Christensen IJ, et al.: Duodenal adenomatosis in familial adenomatous polyposis. Gut 2004, 53:381–386.

    Article  PubMed  CAS  Google Scholar 

  57. Bjork J, Akerbrant H, Iselius L, et al.: Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations. Gastroenterology 2001, 121:1127–1135.

    Article  PubMed  CAS  Google Scholar 

  58. Saurin J-C, Gutknecht C, Napoleon B, et al.: Surveillance of duodenal adenomas in familial adenomatous polyposis reveals high cumulative risk of advanced disease. J Clin Oncol 2004, 22:493–498. Emphasizes the differences in surveillance methods that may account for the disparity in reports on the natural history of duodenal adenomas in FAP.

    Article  PubMed  Google Scholar 

  59. Moozar KL, Madlensky L, Berk T, Gallinger S: Slow progression of periampullary neoplasia in familial adenomatous polyposis. J Gastrointest Surg 2002, 6:831–837.

    Article  PubMed  Google Scholar 

  60. Groves CJ, Saunders BP, Spigelman AD, Phillips RKS: Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study. Gut 2002, 50:636–641. Details the problems inherent in surveillance programs in FAP.

    Article  PubMed  CAS  Google Scholar 

  61. Saurin J-C, Ligneau B, Ponchon T, et al.: The influence of mutation site and age on the severity of duodenal polyposis in patients with familial adenomatous polyposis. Gastrointest Endosc 2002, 55:342–347.

    Article  PubMed  Google Scholar 

  62. Matsumoto T, Iida M, Kobori Y, et al.: Genetic predisposition to clinical manifestations in familial adenomatous polyposis with special reference to duodenal lesions. Am J Gastroenterol 2002, 97:180–185.

    Article  PubMed  Google Scholar 

  63. Moisio A-L, Jarvinen H, Peltomaki P: Genetic and clinical characterization of familial adenomatous polyposis: a population based study. Gut 2002, 50:845–850.

    Article  PubMed  CAS  Google Scholar 

  64. Burke C: Risk stratification for periampullary carcinoma in patients with familial adenomatous polyposis: Does Theodore know what to do now? Gastro 2001, 121:1246–1248.

    Article  CAS  Google Scholar 

  65. Sauerin J-C, Chayvialle JA, Ponchon T: Management of duodenal adenomas in familial adenomatous polyposis. Endoscopy 1999, 31:472–478.

    Article  Google Scholar 

  66. Phillips RKS, Wallace MH, Lynch PM, et al.: A randomized double blind placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut 2002, 50:857–860.

    Article  PubMed  CAS  Google Scholar 

  67. Wallace MH, Forbes A, Beveridge IG, et al.: Randomized, placebo-controlled trial of gastric acid lowering therapy on duodenal polyposis and relative adduct labeling in familial adenomatous polyposis. Dis Colon Rectum 2001, 44:1585–1589.

    Article  PubMed  CAS  Google Scholar 

  68. De Vos tot Nederveen Cappel WH, Jarvinen HJ, Bjork J, et al.: Worldwide survey among polyposis registries of surgical management of severe duodenal adenomatosis in familial adenomatous polyposis. Br J Surg 2003, 90:705–710.

    Article  Google Scholar 

  69. Ruo L, Coit DG, Brennan MF, Guillem JG: Long term follow-up of patients with familial adenomatous polyposis undergoing pancreaticoduodenal surgery. J Gastrointest Surg 2002, 6:671–675.

    Article  PubMed  Google Scholar 

  70. Kalady MR, Clary BM, Tyler DS, Pappas TN: Pancreas-sparing duodenectomy in the management of duodenal familial adenomatous polyposis. J Gastrointest Surg 2002, 6:82–87.

    Article  PubMed  Google Scholar 

  71. Pisters PWT, Hudec W, Hess KR, et al.: Effect of preoperative biliary decompression on pancreaticoduodenectomyassociated morbidity in 300 consecutive patients. Ann Surg 2001, 234:47–55.

    Article  PubMed  CAS  Google Scholar 

  72. Sohn TA, Yeo CJ, Cameron JL, et al.: Do preoperative biliary stents increase postpancreaticoduodenectomy complications? J Gastrointest Surg 2000, 4:258–68.

    Article  PubMed  CAS  Google Scholar 

  73. Huang JJ, Yeo CJ, Sohn TA, et al.: Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg 2000, 231:890–898.

    Article  PubMed  CAS  Google Scholar 

  74. Ortner MEJ, Caca K, Berr F, et al.: Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 2003, 135:1355–1363. Encouraging study that future reports will hopefully validate. Should be read along with editorial by Gores [75].

    Article  Google Scholar 

  75. Gores GJ: A spotlight on cholangiocarcinoma. Gastroenterology 2003, 125:1536–1538.

    Article  PubMed  Google Scholar 

  76. Chang W-H, Karon P, Haber GB: Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest Endosc 1998, 47:354–362.

    Article  PubMed  CAS  Google Scholar 

  77. Dumoulin Fl, Gerhardt T, Fuchs S, et al.: Phase II study of photodynamic therapy and metal stents as palliative treatment for non-resectable hilar cholangiocarcinoma. Gastrointest Endosc 2003, 57:860–867.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastrointestinal Medicine and Nutrition, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 436, 77030, Houston, TX, USA

    William A. Ross MD & Mike M. Bismar MD

Authors
  1. William A. Ross MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mike M. Bismar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ross, W.A., Bismar, M.M. Evaluation and management of periampullary tumors. Curr Gastroenterol Rep 6, 362–370 (2004). https://doi.org/10.1007/s11894-004-0051-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-004-0051-0

Keywords

Search

Navigation